K161100 is an FDA 510(k) clearance for the Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses. This device is classified as a Lens, Contact (other Material) - Daily (Class II - Special Controls, product code HQD).
Submitted by Contamac, Ltd. (Saffron Walden, GB). The FDA issued a Cleared decision on August 10, 2016, 113 days after receiving the submission on April 19, 2016.
This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.5916.
| 510(k) Number | K161100 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | April 19, 2016 |
| Decision Date | August 10, 2016 |
| Days to Decision | 113 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
| Product Code | HQD - Lens, Contact (other Material) - Daily |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 886.5916 |